Darmstadt, Germany

Hans-Michael Eggenweiler

USPTO Granted Patents = 33 


 

Average Co-Inventor Count = 3.0

ph-index = 7

Forward Citations = 133(Granted Patents)


Location History:

  • Weiterstadt, DE (2003 - 2009)
  • Darmstadt, DE (2005 - 2016)

Company Filing History:


Years Active: 2003-2016

Loading Chart...
Loading Chart...
Loading Chart...
33 patents (USPTO):Explore Patents

Title: The Innovations of Hans-Michael Eggenweiler

Introduction

Hans-Michael Eggenweiler is a prominent inventor based in Darmstadt, Germany. With an impressive portfolio of 33 patents, he has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that could aid in the treatment of various diseases including cancer.

Latest Patents

Eggenweiler's latest innovations include two notable patents. The first is focused on pyridine and pyrazine derivatives, which are described as compounds that inhibit TBK1 and IKKε, offering potential treatments for cancer and inflammatory diseases. The second patent involves 3-cyanoaryl-1H-pyrrolo[2,3-B]pyridine derivatives, which share similar applications as the first, indicating his commitment to advancing therapeutic options through innovative chemical structures.

Career Highlights

Throughout his career, Eggenweiler has been associated with reputable companies such as Merck Patent GmbH and Merck Patent Gesellschaft. His work in these organizations has propelled forward the understanding and development of pharmaceutical compounds, showcasing his expertise in patentable inventions critical for the healthcare sector.

Collaborations

In his journey as an inventor, Eggenweiler has collaborated with esteemed colleagues including Michael Wolf and Norbert Beier. These partnerships have likely enriched his research and spurred innovative ideas, further establishing his reputation in the industry.

Conclusion

Hans-Michael Eggenweiler's contributions to pharmaceuticals through his inventions are invaluable. His dedication to innovation and his collaborative endeavors highlight the importance of teamwork in the advancement of scientific research. With a robust array of patents, Eggenweiler remains a key figure in the invention landscape, making strides toward new therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…